Trial
NCT02111551
Phase I Nicotinic Agonist Treatment Trial for Autism
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
—
Condition
Autism
Intervention
DMXB-A 150 mg
Why stopped
difficult to find participants and no funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-06-16